Lineage, Inc. Common Stock (LINE)vsTPG RE Finance Trust Inc (TRTX)
LINE
Lineage, Inc. Common Stock
$44.34
+4.06%
REAL ESTATE · Cap: $11.18B
TRTX
TPG RE Finance Trust Inc
$8.54
-0.23%
REAL ESTATE · Cap: $661.76M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 3835% more annual revenue ($5.36B vs $136.23M). TRTX leads profitability with a 48.1% profit margin vs -2.7%. TRTX earns a higher WallStSmart Score of 68/100 (B-).
LINE
Avoid34
out of 100
Grade: F
TRTX
Strong Buy68
out of 100
Grade: B-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Keeps 48 of every $100 in revenue as profit
Strong operational efficiency at 50.7%
Earnings expanding 58.3% YoY
Attractively priced relative to earnings
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Smaller company, higher risk/reward
ROE of 6.2% — below average capital efficiency
Weak financial health signals
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : TRTX
The strongest argument for TRTX centers on Price/Book, Profit Margin, Operating Margin. Profitability is solid with margins at 48.1% and operating margin at 50.7%. Revenue growth of 11.9% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : TRTX
The primary concerns for TRTX are Market Cap, Return on Equity, Piotroski F-Score. Debt-to-equity of 3.17 is elevated, increasing financial risk.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while TRTX is a mature play — different risk/reward profiles.
TRTX is growing revenue faster at 11.9% — sustainability is the question.
TRTX generates stronger free cash flow (22M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TRTX scores higher overall (68/100 vs 34/100), backed by strong 48.1% margins and 11.9% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →TPG RE Finance Trust Inc
REAL ESTATE · REIT - MORTGAGE · USA
TPG RE Finance Trust, Inc., a commercial real estate finance company, originates, acquires and manages commercial mortgage loans and other commercial real estate-related debt instruments in North America. The company is headquartered in New York, New York.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?